Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MSH5-SAPCD1 readthrough is a chimeric non-coding RNA generated by transcriptional read-through between the MSH5 and SAPCD1 loci. The transcript is a predicted target of nonsense-mediated mRNA decay and is not expected to encode a functional protein. It is classified as a non-coding RNA gene; its biological role, if any, is unknown. Disease associations noted in database records reflect proximity to known disease genes (notably MSH5) rather than independent function or therapeutic relevance for the readthrough itself. There are currently no drugs, validated biomarkers, or known mechanisms of action associated with this transcript[1][3][4][5]. This entry is not a therapeutic target and is likely listed due to confusion with the neighboring, protein-coding MSH5 gene, which is functionally important in DNA repair and meiosis[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MSH5-SAPCD1 readthrough (non-protein coding) (MSH5-SAPCD1).